4//SEC Filing
Panayiotopoulos Paris 4
Accession 0001209191-17-057230
CIK 0001595097other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 7:50 AM ET
Size
5.5 KB
Accession
0001209191-17-057230
Insider Transaction Report
Form 4
Panayiotopoulos Paris
Director
Transactions
- Award
Stock Option(right to buy)
2017-10-16+61,000→ 61,000 totalExercise: $6.90Exp: 2027-10-16→ Common Stock (61,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001662996
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 7:50 AM ET
- Size
- 5.5 KB